Jointown Pharmaceutical Group Co., Ltd (SHA:600998)

Market Cap	25.68B -5.7%
Revenue (ttm)	164.16B +7.0%
Net Income	2.02B -31.3%
EPS	0.39 -32.5%
Shares Out	4.99B
PE Ratio	13.16
Forward PE	11.60
Dividend	0.20 (3.88%)
Ex-Dividend Date	Jun 8, 2026

Volume	39,474,521
Open	5.15
Previous Close	5.15
Day's Range	5.05 - 5.17
52-Week Range	4.48 - 5.84
Beta	0.19
Analysts	Buy
Price Target	5.86 (+13.79%)
Earnings Date	Aug 25, 2026

About SHA:600998

Jointown Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the digital pharmaceutical distribution and supply chain business in China. It operates through Distribution, Industrial, Retail, Medical and Health, and Other divisions. The company offers distribution, warehousing, medical and pharmaceutical logistics, and other services to pharmaceutical manufacturers; medicines and health products; medical, health, and technology value-added services; and digital logistics technology and supply chain solutions. It is also inv...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 29,862
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600998

Financial Performance

In 2025, SHA:600998's revenue was 161.39 billion, an increase of 6.31% compared to the previous year's 151.81 billion. Earnings were 2.25 billion, a decrease of -10.07%.

Analyst Summary

According to 6 analysts, the average rating for 600998 stock is "Buy." The 12-month stock price target is ¥5.86, which is an increase of 13.79% from the latest price.

Price Target

¥5.86

(13.79% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error